Tg(Ins2-CD86)12B70Flv
Transgene Detail
|
Symbol: |
Tg(Ins2-CD86)12B70Flv |
Name: |
transgene insertion 12B70, Richard Flavell |
MGI ID: |
MGI:3764558 |
Synonyms: |
RIP-CD86 |
Transgene: |
Tg(Ins2-CD86)12B70Flv Location: unknown
|
Alliance: |
Tg(Ins2-CD86)12B70Flv page
|
|
Strain of Origin: |
(C57BL/6 x CBA/Ca)F2
|
|
Transgene Type: |
|
Transgenic (Humanized sequence, Inserted expressed sequence) |
Mutation: |
|
Insertion
|
|
|
Tg(Ins2-CD86)12B70Flv expresses
1 gene
Transgene expresses:
Organism |
Expressed Gene |
Homolog in Mouse |
Note |
human |
CD86 (942) |
|
|
|
|
|
Tg(Ins2-CD86)12B70Flv expression driven by
1 gene
Transgene expression driven by:
Organism |
Driver Gene |
Homolog in Mouse |
Note |
rat |
Ins2 (24506) |
|
|
|
|
|
Mutation details: The transgenic construct contains the human CD86 gene driven by the rat insulin 2 promoter (RIP). Transgenic protein expression is restricted to the Islets of Langerhans.
(J:93555)
|
Inheritance: |
|
Dominant |
|
|
View phenotypes and curated references for all genotypes (concatenated display).
|
Mouse strains and cell lines
available from the International Mouse Strain Resource
(IMSR) |
Carrying this Mutation: |
Mouse Strains: 1 strain available
Cell Lines: 0 lines available
|
|
Original: |
J:93555 Guerder S, et al., Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes. J Immunol. 1998 Sep 1;161(5):2128-40 |
All: |
3 reference(s) |
|